Aromatase inhibitors: a new perspective in the treatment of endometriosis

M. Cavagna, D.H. Mendes-Pereira, Edir Catafesta
In: JBRA Assisted Reproduction · 2001 · vol. 5(2) · doi:10.5935/1518-0557.2001.5.2.07 · W4391080030
article OA: bronze CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Aromatase inhibitors may offer a new medical therapy approach for endometriosis by promoting a hypoestrogenic environment, though larger clinical trials are needed to confirm efficacy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The purpose of this articIe is to review some aspects concerning the role of endometriosis in infertility and its medical management.It is referred that aromatase inhibitors may represent a new approach in the medical therapy, since endometriosis is a hormone-dependent disease and the basis of its treatment is the promotion of a hypoestrogenic environment.However, it is registered that large c1inical trials are required to establish the real effectiveness of aromatase inhibitors in the medical management of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK